|
|
2. Progression of type 2
diabetes - inevitable or preventable?
Sunday, September 17, 2000
09:00-12:30
| 09:00-09:10
|
Welcome and Introduction
Itamar Raz, Israel |
| 09:10-09:35
|
Treating type 2 diabetes -
today's targets; tomorrow's goals
George Alberti, UK |
| 09:35-10:00
|
Free fatty acids - do they play
a central role?
Peter Arner, Sweden |
| 09:35-10:00
|
Free fatty acids - do they play
a central role?
Peter Arner, Sweden |
| 10:00-10:25
|
ß-cell deterioration - prospects
for reversal or prevention
Diane T. Finegood, Canada |
| 10:25-10:50
|
Insulin resistance and b-cell
protection - a clinical perspective
David R. Matthews, UK |
| 10:50-11:15 |
Rosiglitazone in type 2
diabetes - how far have we come in preventing the inevitable?
Bernard Zinman, Canada |
| 11:15-11:45
|
Chairperson's summary
Itamar Raz, Israel |
Questions
and Answers
Panel
Close |
 FOR
GENERAL, REGISTRATION AND ABSTRACT ENQUIRIES
PROGRAMME
ICC - Jerusalem International Convention Center - Hall B/C
Itamar Raz, Israel
SmithKline Beecham Pharmaceuticals
FOR
ENQUIRIES
Lorna Meldrum
SmithKline Beecham
SB House
Great West Road
Brentford, UK
Tel: +44 181 9752149
Fax: + 44 181 975 2756
E-mail: lorna.meldrum@sb.com
|
